Black Seed Anxiety Randomized Trial: What the Evidence Says

Black Seed Anxiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are ran

3 min read · 590 wordsReviewed August 2026
High-quality cannabis oil and capsules with hemp seeds and leaf on a dark backdrop. - Evidence evidence guide for black seed anxiety randomized trial
Photo by Kindel Media on Pexels · Pexels License

Quick Answer

Black Seed Anxiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 2 randomized trial.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Black Seed Anxiety Randomized Trial: What the Evidence Says

Quick Answer

Black Seed Anxiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 2 randomized trial.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort randomized trial 2 2026-01-14 10.3390/nu18020255
Effects of grape seed extract supplementation on inflammatory biomarkers, oxidative stress, clinical symptoms, and quality of life in patients with migraine: A double-blinded randomized placebo-controlled clinical trial randomized trial 2 2025-01-01 10.4103/jrms.jrms74225

What The Sources Report

  • The clinical impact is meaningful, as bloating and gas-related symptoms are associated with reduced quality-of-life and higher levels of stress and anxiety. [Allegretti Jessica R. (2026); evidence level 2]
  • Clinically, disruption of GI barrier function is linked to increased sensitivity to visceral and somatic stimuli. [Allegretti Jessica R. (2026); evidence level 2]
  • Migraine symptoms have a negative impact on the patients' quality of life. 2 3 4 5 6 Although the physiopathology of migraine is not fully understood, evidence suggests that mitochondrial dysfunction followed by elevated levels of reactive oxygen species plays an important role in migraine pain. [Eshaghian Niloofar (2025); evidence level 2]
  • Accordingly, previous studies have shown higher levels of oxidative stress in migraine patients than healthy individuals. In addition to oxidative stress, migraine is associated with high levels of inflammatory biomarkers such as calcitonin gene-related peptide (CGRP). [Eshaghian Niloofar (2025); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For black seed anxiety randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 12, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →